Ramucirumab and Atezolizumab After Progression on Any Immune Checkpoint Blocker in NSCLC

Clinical trial NCT03689855 · COMPLETED

Trial details

NCT number: NCT03689855
Sponsor: Washington University School of Medicine
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Non Small Cell Lung Cancer NSCLC

Start date: 2019-06-05
Primary completion: 2021-07-16
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.